Bluefin set to make more acquisitions, says Organ

Robert Organ

Broker's CEO remains positive despite reported loss of £23m in 2014.

Bluefin's CEO Robert Organ was positive about the broker's future growth, following the publication of its financial results for 2014.

The broker reported a £23m loss for the year which was largely due to a goodwill amortisation charge of £16m, but Organ insisted that Bluefin's trading results "remained strong".

He told Insurance Age: "I feel good about the results. They show good progress and we're seeing growth come through. We continue to invest in our business and deliver on our promises."

S

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

This address will be used to create your account

The growing role for brokers in fighting insurance fraud

With reports of fraud escalating in terms of value or number, the role of brokers in combatting these crimes should not be underestimated. Edward Murray looks at the controls, validation tools and processes being implemented to support both detection and prevention.

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: